Watch SRTS. Know when insiders buy.
One email the day a filing lands. Free.
SRTS
Sensus Healthcare, Inc.
2.86
+0.11 +4.00%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
61
WATCH · insiders 80, shorts 42
Insiders, 90 days
+$564K
net buying · 8 buys, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $47.1MP/E —DIV YIELD —FCF YIELD -14.81%REV TTM $17.5M −53.4%NET INCOME −$15.5MNET CASH —52W 2.69 – 5.30SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $2.3M | −68.7% | 33.6% | −$3.2M | −$8.7M | — | -0.53 | −$3.1M | $8K | −$3.1M | Aug 14 |
| Q1 2026 · Mar 31 | $3.4M | −59.3% | 29.2% | −$4.4M | −$2.6M | — | -0.16 | −$3.8M | $3K | −$3.8M | Aug 14 |
| Q4 2025 · Dec 31derived | $4.9M | −62.2% | 38.4% | −$3.1M | −$3.2M | −304.9% | -0.19 | −$2.2M | $158K | −$2.4M | Mar 4 |
| Q3 2025 · Sep 30 | $6.9M | −22.1% | 39.4% | −$2.6M | −$943K | −177.6% | -0.06 | $2.3M | $4K | $2.3M | Nov 12 |
| Q2 2025 · Jun 30 | $7.3M | −20.8% | 39.7% | −$1.9M | −$1M | −164.3% | -0.06 | $3.1M | $27K | $3.1M | Aug 14 |
| Q1 2025 · Mar 31 | $8.3M | −21.7% | 52.2% | −$2.6M | −$2.6M | −213.1% | -0.16 | −$2.7M | $7K | −$2.7M | Aug 14 |
| Q4 2024 · Dec 31derived | $13.1M | +4.0% | 54.4% | $1.7M | $1.5M | −63.3% | 0.10 | −$827K | −$297K | −$530K | Mar 4 |
| Q3 2024 · Sep 30 | $8.8M | +126.8% | 59.3% | $1.5M | $1.2M | — | 0.07 | $4M | $337K | $3.6M | Nov 12 |
| Q2 2024 · Jun 30 | $9.2M | — | 58.7% | $2M | $1.6M | — | 0.10 | $4.2M | $3K | $4.2M | Nov 12 |
| Q1 2024 · Mar 31 | $10.7M | — | 62.5% | $2.9M | $2.3M | — | 0.14 | −$8.2M | $233K | −$8.4M | Nov 12 |
| Q4 2023 · Dec 31derived | $12.6M | — | 62.3% | $5.6M | $4.2M | — | 0.26 | $2.7M | $0 | $2.7M | Mar 5 |
| Q3 2023 · Sep 30 | $3.9M | — | 51.0% | −$1.9M | −$1.5M | — | -0.09 | $442K | $11K | $431K | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $27.5M | 43.2% | −$10.3M | −$7.7M | -28.1% | -0.47 | $528K | $196K | $332K | $300K | — |
| FY2024 · to Dec 31 | $41.8M | 58.4% | $8.1M | $6.6M | 15.9% | 0.41 | −$831K | $276K | −$1.1M | — | — |
| FY2023 · to Dec 31 | $24.4M | 57.6% | −$382K | $485K | 2.0% | 0.03 | −$2.1M | $229K | −$2.4M | $27K | — |
| FY2022 · to Dec 31 | $44.5M | 66.5% | $14.8M | $24.2M | 54.4% | 1.46 | −$1.4M | $159K | −$1.6M | $3M | — |
| FY2021 · to Dec 31 | $27M | 62.8% | $4.1M | $4.1M | 15.2% | 0.25 | −$286K | $128K | −$414K | — | — |
| FY2020 · to Dec 31 | $9.6M | 54.8% | −$8.2M | −$6.8M | -71.4% | -0.42 | −$434K | $359K | −$793K | — | — |
Every number comes from Sensus Healthcare, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.